Akili Interactive Labs
Founded Year
2011Stage
Acq - Pending | AcquiredTotal Raised
$270.4MValuation
$0000About Akili Interactive Labs
Akili Interactive Labs is building clinically validated cognitive treatments and assessments that are delivered in an action video game interface. Leveraging medical-grade science and consumer-grade software technology, the company is seeking to produce a new type of medical product that can offer safe and effective scalable treatment and better patient monitoring for patients across a range of mental health and neurological conditions.
Akili Interactive Labs Headquarter Location
125 Broad Street 5th Floor
Boston, Massachusetts, 02110,
United States
Akili Interactive Labs's Products & Differentiation
See Akili Interactive Labs's products and how their products differentiate from alternatives and competitors
EndeavorRx
The EndeavorRx app is a digital treatment indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD who have a demonstrated attention issue and should be considered for use as part of a therapeutic program. EndeavorRx is an FDA-cleared medical device and must be prescribed by a healthcare professional. It is not intended as a stand-alone therapeutic, nor is it a substitute for a child’s medication.
Differentiation
EndeavorRx is the only prescription video game available for the treatment of ADHD.
Research containing Akili Interactive Labs
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Akili Interactive Labs in 10 CB Insights research briefs, most recently on Dec 8, 2021.
Dec 8, 2021 report
The Digital Health 150: The Top Digital Health Companies Of 2021
Mar 12, 2020
100+ Of The Most Well-Funded Medical Device Startups
Expert Collections containing Akili Interactive Labs
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Akili Interactive Labs is included in 6 Expert Collections, including Digital Health.
Digital Health
13,489 items
Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)
Mental Health Tech
1,215 items
This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.
Digital Health 150
300 items
2019's cohort of the most promising digital health startups transforming the healthcare industry
Medical Devices
12,028 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Biopharma Tech
15,795 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Health IT
7,900 items
Akili Interactive Labs Patents
Akili Interactive Labs has filed 22 patents.
The 3 most popular patent topics include:
- Cognition
- Cognitive tests
- Psychiatric diagnosis
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/25/2017 | 4/19/2022 | Cognitive biases, Physical exercise, Cognition, Cognitive tests, Educational psychology | Grant |
Application Date | 8/25/2017 |
|---|---|
Grant Date | 4/19/2022 |
Title | |
Related Topics | Cognitive biases, Physical exercise, Cognition, Cognitive tests, Educational psychology |
Status | Grant |
Latest Akili Interactive Labs News
Jun 7, 2022
Franklin becomes president and COO at PureTech’s Akili Plus new CMOs at Artiva and Third Harmonic, and updates from Dotmatics By Richard Guy, Biopharma Analyst and Gunjan Ohri, Data Content Analyst June 7, 2022 12:01 AM UTC Akili Interactive Labs Inc. hired Matt Franklin in the newly created role of president and COO, effective June 21. Franklin was the general manager of precision oncology business unit at Exact ... Access this Article
Akili Interactive Labs Web Traffic
Akili Interactive Labs Rank
When was Akili Interactive Labs founded?
Akili Interactive Labs was founded in 2011.
Where is Akili Interactive Labs's headquarters?
Akili Interactive Labs's headquarters is located at 125 Broad Street, Boston.
What is Akili Interactive Labs's latest funding round?
Akili Interactive Labs's latest funding round is Acq - Pending.
How much did Akili Interactive Labs raise?
Akili Interactive Labs raised a total of $270.4M.
Who are the investors of Akili Interactive Labs?
Investors of Akili Interactive Labs include Social Capital Suvretta Holdings I, Jazz Venture Partners, Evidity Health Capital, Amgen Ventures, Baillie Gifford & Co. and 21 more.
Who are Akili Interactive Labs's competitors?
Competitors of Akili Interactive Labs include Pear Therapeutics and 8 more.
What products does Akili Interactive Labs offer?
Akili Interactive Labs's products include EndeavorRx.
You May Also Like
Pear Therapeutics discovers, develops, and delivers clinically-validated Prescription Digital Therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effection solutions for payers.
Happify is a LifeTech company that delivers digital therapeutics and care delivery models to improve mental and physical health. Happify Health’s safe, effective digital tools use scientific research from positive psychology, CBT, and mindfulness, combined with a gamified approach and technology, to impact everyday lives. Happify Health's clinically-validated platform provides global access to a comprehensive, evidence-based intervention catalog.
Limbix makes virtual reality and digital treatment tools for therapists.
Click Therapeutics develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click's Digital Therapeutics enable change within individuals and are designed to be used independently or in conjunction with biomedical treatments. Click's smoking cessation program is currently available nationwide through a variety of payers, providers, and employers. Click Therapeutics was founded in 2012 and is based in New York, New York.
Cognoa’s AI-driven products enable early intervention of behavioral health conditions to improve lifelong outcomes. The firm develops prescription digital therapeutics for the earlier identification and treatment of behavioral health conditions in order to change the standard of care and improve lifelong outcomes for children.
Elemy is a provider of in-home and online pediatric behavioral care, including pediatric autism.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.